Lotus Bio-Technology Development (Lotus Bio-Technology Development) Liabilities-to-Assets : 2.13 (As of Dec. 2017)

Lotus Bio-Technology Development Liabilities-to-Assets Chart

Lotus Bio-Technology Development Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17
Liabilities-to-Assets	Get a 7-Day Free Trial															22.00	-	-	-	2.13

Competitive Comparison of Lotus Bio-Technology Development's Liabilities-to-Assets

For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lotus Bio-Technology Development's Liabilities-to-Assets Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Lotus Bio-Technology Development's Liabilities-to-Assets falls into.

Lotus Bio-Technology Development Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Lotus Bio-Technology Development's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2017 is calculated as:

Lotus Bio-Technology Development's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development  (OTCPK:LBTD) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Lotus Bio-Technology Development Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Lotus Bio-Technology Development's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lotus Bio-Technology Development (Lotus Bio-Technology Development) Business Description